Corcept Therap
CORT----
Corcept Therap (CORT)
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologi...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Corcept Therap Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$106.0011.16%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 17 hours ago
Fifth Third Bancorp Grows Stock Holdings in Corcept Therapeutics Incorporated $CORT
- PUBT · 1 day ago, 08:03 AM
Berkshire’s CORT signs deal to buy Dwellworks Living
- Market Beat · 1 day ago, 02:56 AM
Corcept Therapeutics (CORT) Expected to Post Earnings on Thursday
- PUBT · 2 days ago, 03:05 PM
Corcept Therapeutics schedules second-quarter results conference call
- Global Report · 2 days ago, 04:18 AM
The Great Fragmentation of 2026: Consumer Resilience, Biotech Highs, and Web3 Ghosts
- PUBT · Jul 17 at 05:32 PM
Corcept Therapeutics CFO Atabak Mokari disposes of 40,000 common shares for $3.52 million
